Logo image of CRI

CARTER'S INC (CRI) Stock Fundamental Analysis

NYSE:CRI - US1462291097 - Common Stock

26.29 USD
+0.97 (+3.83%)
Last: 8/22/2025, 8:04:00 PM
26.3 USD
+0.01 (+0.04%)
After Hours: 8/22/2025, 8:04:00 PM
Fundamental Rating

5

CRI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. CRI has only an average score on both its financial health and profitability. CRI is cheap, but on the other hand it scores bad on growth. Finally CRI also has an excellent dividend rating. This makes CRI very considerable for value and dividend investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CRI was profitable.
In the past year CRI had a positive cash flow from operations.
CRI had positive earnings in each of the past 5 years.
Each year in the past 5 years CRI had a positive operating cash flow.
CRI Yearly Net Income VS EBIT VS OCF VS FCFCRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

The Return On Assets of CRI (5.41%) is better than 70.00% of its industry peers.
CRI has a Return On Equity of 15.55%. This is in the better half of the industry: CRI outperforms 74.00% of its industry peers.
CRI has a Return On Invested Capital of 8.98%. This is in the better half of the industry: CRI outperforms 62.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRI is above the industry average of 10.63%.
The 3 year average ROIC (13.75%) for CRI is well above the current ROIC(8.98%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.41%
ROE 15.55%
ROIC 8.98%
ROA(3y)9.05%
ROA(5y)8.18%
ROE(3y)26.4%
ROE(5y)25.22%
ROIC(3y)13.75%
ROIC(5y)13.22%
CRI Yearly ROA, ROE, ROICCRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With a decent Profit Margin value of 4.69%, CRI is doing good in the industry, outperforming 68.00% of the companies in the same industry.
CRI's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 7.78%, CRI is in line with its industry, outperforming 58.00% of the companies in the same industry.
CRI's Operating Margin has declined in the last couple of years.
The Gross Margin of CRI (47.29%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CRI has grown nicely.
Industry RankSector Rank
OM 7.78%
PM (TTM) 4.69%
GM 47.29%
OM growth 3Y-11.06%
OM growth 5Y-2.63%
PM growth 3Y-12.75%
PM growth 5Y-2.95%
GM growth 3Y0.38%
GM growth 5Y2.29%
CRI Yearly Profit, Operating, Gross MarginsCRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

CRI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CRI has less shares outstanding
CRI has less shares outstanding than it did 5 years ago.
CRI has a better debt/assets ratio than last year.
CRI Yearly Shares OutstandingCRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRI Yearly Total Debt VS Total AssetsCRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.62 indicates that CRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.62, CRI is in line with its industry, outperforming 48.00% of the companies in the same industry.
CRI has a debt to FCF ratio of 3.55. This is a good value and a sign of high solvency as CRI would need 3.55 years to pay back of all of its debts.
CRI's Debt to FCF ratio of 3.55 is fine compared to the rest of the industry. CRI outperforms 68.00% of its industry peers.
A Debt/Equity ratio of 0.58 indicates that CRI is somewhat dependend on debt financing.
CRI's Debt to Equity ratio of 0.58 is on the low side compared to the rest of the industry. CRI is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 3.55
Altman-Z 2.62
ROIC/WACC0.98
WACC9.12%
CRI Yearly LT Debt VS Equity VS FCFCRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.20 indicates that CRI has no problem at all paying its short term obligations.
The Current ratio of CRI (2.20) is better than 64.00% of its industry peers.
CRI has a Quick Ratio of 1.03. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.03, CRI is in line with its industry, outperforming 46.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.03
CRI Yearly Current Assets VS Current LiabilitesCRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1

3. Growth

3.1 Past

The earnings per share for CRI have decreased strongly by -20.31% in the last year.
The Earnings Per Share has been decreasing by -1.36% on average over the past years.
Looking at the last year, CRI shows a very negative growth in Revenue. The Revenue has decreased by -19.89% in the last year.
Measured over the past years, CRI shows a decrease in Revenue. The Revenue has been decreasing by -4.17% on average per year.
EPS 1Y (TTM)-20.31%
EPS 3Y-8.37%
EPS 5Y-1.36%
EPS Q2Q%-77.63%
Revenue 1Y (TTM)-19.89%
Revenue growth 3Y-6.56%
Revenue growth 5Y-4.17%
Sales Q2Q%3.7%

3.2 Future

CRI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -25.63% yearly.
CRI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.45% yearly.
EPS Next Y-47.73%
EPS Next 2Y-37.89%
EPS Next 3Y-25.63%
EPS Next 5YN/A
Revenue Next Year0.6%
Revenue Next 2Y-0.09%
Revenue Next 3Y-0.45%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CRI Yearly Revenue VS EstimatesCRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CRI Yearly EPS VS EstimatesCRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.15, the valuation of CRI can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of CRI indicates a rather cheap valuation: CRI is cheaper than 98.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.24, CRI is valued rather cheaply.
A Price/Forward Earnings ratio of 11.23 indicates a reasonable valuation of CRI.
Based on the Price/Forward Earnings ratio, CRI is valued a bit cheaper than 80.00% of the companies in the same industry.
CRI is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.81, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.15
Fwd PE 11.23
CRI Price Earnings VS Forward Price EarningsCRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRI is valued cheaply inside the industry as 96.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRI indicates a rather cheap valuation: CRI is cheaper than 88.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.82
EV/EBITDA 4.05
CRI Per share dataCRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The decent profitability rating of CRI may justify a higher PE ratio.
A cheap valuation may be justified as CRI's earnings are expected to decrease with -25.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-37.89%
EPS Next 3Y-25.63%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.47%, CRI is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.65, CRI pays a better dividend. On top of this CRI pays more dividend than 98.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, CRI pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.47%

5.2 History

The dividend of CRI is nicely growing with an annual growth rate of 16.75%!
CRI has paid a dividend for at least 10 years, which is a reliable track record.
CRI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)16.75%
Div Incr Years1
Div Non Decr Years4
CRI Yearly Dividends per shareCRI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

72.12% of the earnings are spent on dividend by CRI. This is not a sustainable payout ratio.
The Dividend Rate of CRI has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP72.12%
EPS Next 2Y-37.89%
EPS Next 3Y-25.63%
CRI Yearly Income VS Free CF VS DividendCRI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
CRI Dividend Payout.CRI Dividend Payout, showing the Payout Ratio.CRI Dividend Payout.PayoutRetained Earnings

CARTER'S INC

NYSE:CRI (8/22/2025, 8:04:00 PM)

After market: 26.3 +0.01 (+0.04%)

26.29

+0.97 (+3.83%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)07-25 2025-07-25/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners122.72%
Inst Owner Change1.03%
Ins Owners2.6%
Ins Owner Change17.49%
Market Cap957.74M
Analysts46.15
Price Target25.09 (-4.56%)
Short Float %13.86%
Short Ratio2.99
Dividend
Industry RankSector Rank
Dividend Yield 10.47%
Yearly Dividend3.2
Dividend Growth(5Y)16.75%
DP72.12%
Div Incr Years1
Div Non Decr Years4
Ex-Date08-26 2025-08-26 (0.25)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.79%
Min EPS beat(2)-56.97%
Max EPS beat(2)23.39%
EPS beat(4)3
Avg EPS beat(4)4.81%
Min EPS beat(4)-56.97%
Max EPS beat(4)33.81%
EPS beat(8)7
Avg EPS beat(8)16.16%
EPS beat(12)10
Avg EPS beat(12)20.07%
EPS beat(16)13
Avg EPS beat(16)16.28%
Revenue beat(2)1
Avg Revenue beat(2)1.26%
Min Revenue beat(2)-0.04%
Max Revenue beat(2)2.56%
Revenue beat(4)2
Avg Revenue beat(4)0.88%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)2.56%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.25%
PT rev (1m)-16.89%
PT rev (3m)-15.17%
EPS NQ rev (1m)-6.96%
EPS NQ rev (3m)-36.99%
EPS NY rev (1m)-7%
EPS NY rev (3m)-4.81%
Revenue NQ rev (1m)1.7%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)1.85%
Revenue NY rev (3m)2.25%
Valuation
Industry RankSector Rank
PE 5.15
Fwd PE 11.23
P/S 0.34
P/FCF 6.82
P/OCF 4.82
P/B 1.12
P/tB 2.7
EV/EBITDA 4.05
EPS(TTM)5.1
EY19.4%
EPS(NY)2.34
Fwd EY8.91%
FCF(TTM)3.85
FCFY14.66%
OCF(TTM)5.46
OCFY20.75%
SpS77.77
BVpS23.44
TBVpS9.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.41%
ROE 15.55%
ROCE 11.42%
ROIC 8.98%
ROICexc 10.89%
ROICexgc 15.87%
OM 7.78%
PM (TTM) 4.69%
GM 47.29%
FCFM 4.95%
ROA(3y)9.05%
ROA(5y)8.18%
ROE(3y)26.4%
ROE(5y)25.22%
ROIC(3y)13.75%
ROIC(5y)13.22%
ROICexc(3y)16.52%
ROICexc(5y)18.31%
ROICexgc(3y)24.79%
ROICexgc(5y)28.26%
ROCE(3y)17.48%
ROCE(5y)16.81%
ROICexcg growth 3Y-19.15%
ROICexcg growth 5Y0.36%
ROICexc growth 3Y-17.36%
ROICexc growth 5Y-0.7%
OM growth 3Y-11.06%
OM growth 5Y-2.63%
PM growth 3Y-12.75%
PM growth 5Y-2.95%
GM growth 3Y0.38%
GM growth 5Y2.29%
F-Score6
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 3.55
Debt/EBITDA 1.81
Cap/Depr 105.23%
Cap/Sales 2.06%
Interest Coverage 250
Cash Conversion 72.04%
Profit Quality 105.68%
Current Ratio 2.2
Quick Ratio 1.03
Altman-Z 2.62
F-Score6
WACC9.12%
ROIC/WACC0.98
Cap/Depr(3y)84.08%
Cap/Depr(5y)65.4%
Cap/Sales(3y)1.75%
Cap/Sales(5y)1.49%
Profit Quality(3y)119.52%
Profit Quality(5y)187.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.31%
EPS 3Y-8.37%
EPS 5Y-1.36%
EPS Q2Q%-77.63%
EPS Next Y-47.73%
EPS Next 2Y-37.89%
EPS Next 3Y-25.63%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.89%
Revenue growth 3Y-6.56%
Revenue growth 5Y-4.17%
Sales Q2Q%3.7%
Revenue Next Year0.6%
Revenue Next 2Y-0.09%
Revenue Next 3Y-0.45%
Revenue Next 5YN/A
EBIT growth 1Y-41.85%
EBIT growth 3Y-16.9%
EBIT growth 5Y-6.69%
EBIT Next Year-14.39%
EBIT Next 3Y-8.04%
EBIT Next 5YN/A
FCF growth 1Y-58.81%
FCF growth 3Y1.66%
FCF growth 5Y-5.73%
OCF growth 1Y-49.2%
OCF growth 3Y3.65%
OCF growth 5Y-5.05%